Tennis legend Serena Williams is sharing her journey with weight loss drugs, saying she's lost 31 pounds in 8 months using GLP-1s.

A retrospective macro-study revealed that the use of GLP-1 agonists is associated with a reduction in the overall risk of cancer among obese or overweight patients ...

Pedersen and Maggie Fick COPENHAGEN (Reuters) -As Novo Nordisk's sales of its blockbuster weight-loss drug Wegovy boomed, the ...

Williams joins a growing list of celebrities who have publicly shared their use of weight loss medications, including Oprah Winfrey, Whoopi Goldberg, singer Meghan Trainor and basketball legend ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Wegovy is now the second medicine approved in the U.S. for a disease that affects millions. Novo Nordisk has several other factors working in its favor, including strong results and a solid pipeline.

Biotech firm Vivani Medical has joined hands with Okava to work on a canine-friendly version of weight loss medications ...

Novo Nordisk raced to meet demand for its weight-loss drug Wegovy and almost doubled its workforce over five years. Now, the ...

Many Mounjaro users have considered making the swap after Eli Lilly announced prices would be increasing in the UK by 170 ...

Taking meds to lose weight has been surging among Americans. While these drugs are safe, they have one drawback, they can also cause muscle mass loss.

Patients' vision loss, which is rare according to a new study, is also the subject of multiple lawsuits, including two filed ...